We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Blackstone
BX
$86.2B
| $1.16M | 0.63% |
35,665
| – | – |
2013 Q2
3 quarters
|
|
27
Salesforce
CRM
$193B
| $1.14M | 0.62% |
+20,000
| New | +$1.2M |
2014 Q1
0 quarters
|
|
|
COWN
28
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.06M | 0.57% |
59,876
| – | – |
2013 Q2
3 quarters
|
|
29
DexCom
DXCM
$32.4B
| $1.03M | 0.56% |
100,000
| – | – |
2013 Q2
3 quarters
|
|
30
Viavi Solutions
VIAV
$10.3B
| $980K | 0.53% |
123,060
+70,320
| +133% | +$531K |
2013 Q4
1 quarter
|
|
31
CALL
ExxonMobil
XOM
$708B
| $977K | 0.53% |
10,000
| – | – |
2013 Q4
1 quarter
|
|
32
Insulet
PODD
$9.7B
| $948K | 0.51% |
20,000
| – | – |
2013 Q2
3 quarters
|
|
33
Popular Inc
BPOP
$9.98B
| $930K | 0.5% |
+30,000
| New | +$854K |
2014 Q1
0 quarters
|
|
34
Halozyme
HALO
$12.6B
| $928K | 0.5% |
73,050
+8,050
| +12% | +$119K |
2013 Q2
3 quarters
|
|
|
FSGI
35
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
| $900K | 0.49% |
600,000
| – | – |
2013 Q2
3 quarters
|
|
|
CODE
36
DELISTED
SPANSION INC, CLASS A COMMON STOCK
CODE
| $871K | 0.47% |
50,000
+25,000
| +100% | +$393K |
2013 Q4
1 quarter
|
|
|
CGRN
37
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
| $852K | 0.46% |
2,000
| – | – |
2013 Q2
3 quarters
|
|
|
RKUS
38
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $851K | 0.46% |
70,000
+35,000
| +100% | +$483K |
2013 Q2
3 quarters
|
|
|
EAGLW
39
DELISTED
GLOBAL EAGLE ACQUISITION CORP WTS EXP 05-13-2016 (DE)
EAGLW
| $848K | 0.46% |
155,000
| – | – |
2013 Q2
3 quarters
|
|
|
TYC
40
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $848K | 0.46% |
19,100
| – | – |
2013 Q4
1 quarter
|
|
41
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $822K | 0.44% |
100,000
| – | – |
2013 Q2
3 quarters
|
|
42
DELISTED
Farmer Brothers
FARM
| $798K | 0.43% |
40,500
| – | – |
2013 Q2
3 quarters
|
|
|
SGEN
43
DELISTED
Seagen Inc. Common Stock
SGEN
| $797K | 0.43% |
17,500
+2,500
| +17% | +$120K |
2013 Q2
3 quarters
|
|
44
Puma Biotechnology
PBYI
$531M
| $795K | 0.43% |
7,630
+2,600
| +52% | +$306K |
2013 Q2
3 quarters
|
|
45
Teva Pharmaceutical Industries Limited
TEVA
$48B
| $793K | 0.43% |
+15,000
| New | +$693K |
2014 Q1
0 quarters
|
|
46
DELISTED
Revance Therapeutics, Inc.
RVNC
| $788K | 0.43% |
+25,000
| New | +$781K |
2014 Q1
0 quarters
|
|
47
Blackstone Mortgage Trust
BXMT
$1.83B
| $779K | 0.42% |
27,100
-2,400
| -8% | -$68K |
2013 Q2
3 quarters
|
|
|
FRE.PRZ
48
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
| $770K | 0.42% |
70,000
+15,000
| +27% | +$165K |
2013 Q2
3 quarters
|
|
|
TNGO
49
DELISTED
Tangoe, Inc.
TNGO
| $744K | 0.4% |
40,000
+15,000
| +60% | +$276K |
2013 Q4
1 quarter
|
|
|
FNM.PRS
50
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
| $734K | 0.4% |
70,000
+15,000
| +27% | +$157K |
2013 Q3
2 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.